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Abstract 
 
Background 
The burden of HIV/AIDS in Ethiopia has not been comprehensively assessed over the 
last two decades. In this study, we used the 2016 Global Burden of Diseases, Injuries and 
Risk factors (GBD) data to analyze the incidence, prevalence, mortality and Disability-
adjusted Life Years Lost(DALY) rates of Human Immunodeficiency Virus infection/ 
Acquired Immune Deficiency Syndrome (HIV/AIDS) in Ethiopia over the last 25 years. 
Methods 
The GBD 2016 used a wide range of data source for Ethiopia such as verbal autopsy 
(VA), surveys, reports of Federal Ministry of Health and United Nations (UN) and 
published scientific articles. The modified United Nations Programme on HIV/AIDS 
(UNAIDS) Spectrum model was used to estimate the incidence and mortality rates for 
HIV/AIDS.  
Results 
In 2016, an estimated 36,990 new HIV infections (95% uncertainty interval [UI]: 8775-
80262), 670,906 prevalent HIV cases (95% UI: 568,268-798,970) and 19,999 HIV deaths 
(95% UI: 16426-24412) occurred in Ethiopia. The HIV/AIDS incidence rate peaked in 
1995 and declined by 6.3% annually for both sexes with a total reduction of 77% between 
1990 and 2016. Annualized HIV/AIDS mortality rate reduction during 1990 to 2016 for 
both sexes was 0.4%. 
Conclusions 
Ethiopia has achieved the 50% reduction of the incidence rate of HIV/AIDS based on the 
Millennium Development Goals (MDGs) target. However, the decline in HIV/AIDS 
mortality rate has been comparatively slow. The country should strengthen the 
HIV/AIDS detection and treatment programs at community level to achieve its targets 
during the Sustainable Development Program (SDGs)-era.   
Background 
 
The global momentum of HIV/AIDS interventions has been intensified since the launch 
of the Millennium Development Goals (MDG) that aimed to reduce the incidence of 
HIV/AIDS by 50% by 2015(1, 2).  However, HIV/AIDS is still the major public health 
problems globally.  In 2015, there were about 1.1 million HIV/AIDS deaths, 2.1 million 
new HIV infections and a total of 36.7 million people who have HIV in their blood. Sub-
Saharan Africa is the most affected region, with 25.6 million people living with HIV in 
2015(3).  
The burden of HIV/AIDS remains high in Ethiopia despite a considerable scale up of 
comprehensive HIV/AIDS interventions during the MDG period. In 2016, there were 
about 718,500 people living with HIV/AIDS(4).  The 2017 UNAID global AIDS report 
revealed that the number of new HIV infections in Ethiopia were higher in 2016 than 
2010 (5). The re-emergence of HIV/AIDS in Ethiopia could be due to the low coverage 
of high impact interventions. For instance, the 59% coverage of Highly Active 
Antiretroviral Treatment (HAART) in Ethiopia is below the regional average and only 
67% of Ethiopian know their HIV status (5). 
Achievement of the HIV/AIDS related Sustainable Development Goals (SDGs) in 
Ethiopia requires concerted efforts of scaling up comprehensive HIV/AIDS interventions 
and a robust health management information system (HMIS) that helps to evaluate the 
burden of HIV/AIDS. Over the last two decades the prevalence, incidence and number of 
AIDS deaths have been estimated in Ethiopia using the Antenatal care (ANC) based 
sentinel surveillance system(6). In this paper, we used the Global Burden of Diseases 
(GBD) 2016 data (7-10) to assess the burden (prevalence, incidence, mortality and 
Disability-adjusted Life Years Lost rates) of HIV/AIDS over the last 26 years. There are 
several reasons to use the GBD data: First, it employs rigorous methods to estimate rates 
including DALY as described in the methods section of this paper; second, GBD uses a 
standardized methodology that is very essential to compare the performance of Ethiopia 
with other countries in terms of achieving the HIV/AIDS related targets.  The study 
provides reliable information on the achievement of HIV-related targets of the MDG. It 
also helps decision makers to allocate resources based on the burden of HIV/AIDS. 
Lastly, the study will serve as a baseline indicator to track progresses during the SDG era.    
Methods  
 
Ethiopian population (approximately 100 million) is the second largest in Africa with  
diverse population mix and unique cultural heritage(11). The GBD 2016 data were used 
to analyze the incidence, prevalence and mortality rates of HIV/AIDS.  The GBD 2016 
utilizes comprehensive sources of data and rigorous analysis to estimate trends of cause-
specific mortality rates and risk factors for 188 countries (7, 8, 10, 12).  
Data sources 
The study employed a mathematical modeling using the GBD data. The GBD 2016 used 
a wide range of HIV/AIDS data for Ethiopia (http://ghdx.healthdata.org/). The key 
sources of data for HIV/AIDS include verbal autopsy, Demographic and Health Surveys 
(DHS) and data reported by the Ministry of Health to UNAIDS via the Spectrum 
software (12, 13). In addition, cohort data from throughout sub-Saharan Africa was used 
to estimate input parameters to the Ethiopia HIV epidemic model. 
Analysis strategies 
The GBD uses recoded versions of the Epidemic and Projection Package (EPP) and 
Spectrum model which allow for draw-level linkage between HIV estimates and all-cause 
mortality estimates (14, 15).  The GBD populations and vital rates are used as inputs to 
the population projections within EPP and Spectrum. HIV mortality and disease 
progression parameters estimates differ from UNAIDS due to different data sources and 
modelling strategies. Within Spectrum, GBD methods included a novel approach to 
allocating ART across CD4 count groups with coverage distributions estimated using 
data from systematic review and survey. Estimates of HIV-specific mortality from the 
life table process are averaged with mortality rates coming from the epidemic model and, 
in order to preserve prevalence estimates, new HIV infections are back-calculated to 
align with updated mortality (10). Causes of death by age groups, sex, and year for other 
diseases were measured using CODEm. A detailed description of CODEm is reported 
elsewhere (12, 16-18). In summary, CODEm tests and selects the best-performing model 
from a wide range of models such as mixed-effects linear models and spatiotemporal 
Gaussian process regression (ST-GPR) models in predicting mortality rates and cause 
fractions (12). 
 
Quality assurance 
The GBD 2016 analysis uses reliable data including DHS, published articles and ministry 
of health reports. Unpublished data from other sources were excluded.  
Ethical approval 
The study used a secondary data from the GBD 2016 study and permission was obtained 
from Institute of Health Metrics and Evaluation to utilize the data. The GBD 2016 data 
are available and can be accessed at the GBD website (http://vizhub.healthdata.org/gbd-
compare/). 
 
Results 
 
Incidence 
 In 2016, there were an estimated 36,990 new HIV infections for all ages and sex (95% 
UI: 8775-80,262) in Ethiopia. The age-standardised incidence rate declined from 
178/100,000 to 40/100,000 between 1990 and 2016 with a total reduction of 77%. HIV 
incidence rate peaked in 1995 and declined steadily till 2005 and became stable since 
2005. The annualized rate of change (ARC) for the HIV incidence rate during 1990 and 
2016 was -6.3% (Figure 1).  
Prevalence 
 An estimated of 670,906 (95% UI: 568, 268-798, 970) people living with HIV were 
registered in 2016. The number of females with HIV/AIDS (385,642) were higher than 
the number of males (285,263) with HIV/AIDS in 2016. The age-standardised HIV 
prevalence rate peaked in 2000(1984 cases/100,000) and declined steadily until 2010 and 
remain stable thereafter (Figure 2).   
Mortality 
In 2016, nearly 20,000 AIDS related deaths (95% UI: 16,426-24,412) occurred in 
Ethiopia. AIDS mortality rate peaked in 2005(150/100,000). The age-standardised AIDS 
mortality rate declined very fast after 2005 and reach to 24/100,000 in 2016 (Table 1). In 
2016, the number of HIV/AIDS deaths and mortality rate was highest in the age group of 
35-54 years and males and females had similar mortality pattern (Figure 3).  
 DALY 
An estimated of 1.1 million (95%UI: 0.9million-1.4million) AIDS related DALY were 
registered in Ethiopia in 2016. Age-standardised AIDS DALY rate progressively 
increased between 1990 and 2005 and declined steadily since 2005 (Table 2).  
 
Discussion 
 
Ethiopia has shown remarkable progress in reducing the burden and reversing epidemic 
of HIV/AIDS in the last two decades. The country reduced the incidence of HIV/AIDS 
by 77%, which surpasses the MDG target of 50% incidence reduction(2). 
 Other reports of the United Nations (UN) also show that that Ethiopia has achieved most 
of the MDG targets related to HIV (19, 20). However, there were very few studies that 
evaluated the burden of HIV/AIDS in Ethiopia.  Hladik and colleagues have reported that 
the prevalence of HIV/AIDS in Ethiopia was below 2% in 1990 and reached to 4.4% in 
2003 and remain stable until 2008(21). In the same study, the incidence rate of 
HIV/AIDS was 0.5% and 3.3% in rural and urban areas respectively in 1990. The 
modeled adult HIV incidence by the same authors for all Ethiopia showed a steady but 
slow growth to 0.68% in 2003 and stabilized for the years 2004–08 (21).  
The current study using GBD data reveals that prevalence reaches its peak (2%) in 2000 
and declines to 1% in 2010 and remain stable. In addition, our study shows that the 
incidence rate steadily increases until 1995(0.3%) and dramatically decline to 0.04% in 
2005 and remain stable. The prevalence and incidence rates in the GBD estimates are 
lower than the estimates made by Hladik et al. (21).  
Our estimates of number of AIDS deaths (n=20,000) and number of people living with 
HIV (n=670,906) in 2016 were different from the estimates of Ethiopian Public Health 
Institute (EPHI) and UNAIDS report (5, 22). Although the EPHI mortality estimate in 
2016(n=19, 743) is nearly the same as our estimate, GBD underestimates the number of 
people living with HIV compared to the EPHI estimate in the same year (n=718,500). On 
the other hand, the prevalence of HIV/AIDS in 2015 (1.21%) and 2016(1.18%) estimated 
by the Ethiopian Public Health Institute (EPHI) is similar to the GBD estimate(22). 
The differences in GBD estimates and other methods that uses EPP could be due to the 
methodological differences where GBD has modified the EPP and the Spectrum in 
several ways as discussed in the previous sections and described in detail elsewhere(12).  
The performance of Ethiopia in reducing the burden of HIV/AIDS and reversing this 
epidemic is remarkable particularly since 2000 (12). Several factors could have helped 
Ethiopia to achieve the MDG targets. The strong government leadership and political 
commitment in designing and implementing primary health care driven health services 
could have helped Ethiopia to achieve most of the MDG targets(23). The country has also 
implemented an innovative community-based health service delivery called Health 
Extension Program (HEP) since 2003(23). Salaried and trained female Health Extension 
Workers (HEW) are involved in the HEP to give basic health package within the 
community. The HEW uses family folder at Kebele (lowest administrative unit) level to 
monitor the health service delivery and health status of the population. The HEP and the 
Family Folder have been instrumental to make health services accessible to the poor (20, 
23-25). The HEP could be one of the contributors of an improved annual rate of change 
for the mortality rates of HIV/AIDS (11%) between 2003 and 2015 (26). 
The expansion of antiretroviral treatment (ART) free of charge since 2003 could be 
instrumental to reduce the incidence and mortality rates of HIV/AIDS (27). As a result of 
government commitment and direction, ART delivery has been scaled down to the 
primary health care unit to ensure better coverage and utilization by the poor (28). Some 
studies show that mortality decline among individuals living with HIV/AIDS in Ethiopia 
is consistent with ART coverage and uptake (29, 30). However, the ART coverage in 
adults (59%) and children (23%) is still very low in Ethiopia, which leads vulnerable 
population to premature mortality (5, 31). The contribution of development partners to 
fight HIV/AIDS and TB (PEPFAR) has been also vital in fighting HIV/AIDS and TB in 
Ethiopia. The government has used flexible modalities of One-plan, One-budget and 
One-Report concept and effectively utilized the funding to scale up interventions towards 
HIV/AIDS and TB(32). Donors’ funding could decline during the coming years and 
Ethiopia should strengthen the low-cost and high impact HEP-based interventions to 
sustain progress (11, 33).  
Despite considerable progress in the past, Ethiopia has now several challenges to achieve 
the 90-90-90 global targets of HIV/AIDS by 2020(5). Based on these global targets, 90% 
of the population should know their HIV status; 90% of those who know their HIV 
should be treated and 90% of the treated should be virally suppressed by 2020(5). There 
are several barriers for Ethiopia to achieve these targets in the coming years.  TB/HIV co-
infection and its impact on stigma and mental health problems could also be a big hurdle 
to for the HIV/AIDS control program (34, 35). In the rural part of the country, stigma and 
prejudices are still widespread which needs tailored intervention (36). Though continuous 
community mobilization, stigma reduction and care and support services has been vital 
for increasing utilization of ART services and improving retention in care that helps to 
reduce early mortality due to HIV/AIDS in Ethiopia (27). On the other hand, the level of 
funding for HIV/AIDS has declined recently that may affect the momentum of HIV 
interventions in Ethiopia.  
 
 
This study is based on the GBD 2016 that uses comprehensive data sources and rigorous 
analysis. However, the study has some limitations. First, the use of verbal autopsy (VA) 
data in morality estimation may introduce misclassification bias. Use of published articles 
could introduce publication bias since unfavorable findings may not be published.  
In conclusion, Ethiopia has achieved most of the MDG targets related to HIV/AIDS 
However; the decline in HIV/AIDS mortality rate has been slow. Ethiopia should 
strengthen HIV case detection and treatment programs at community level through the 
HEP to reduce the burden of these diseases during the SDG-era.   
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Figure 1: Number of New HIV infection (A) and HIV/AIDS incidence rate (B) by sex 
between 1990 and 2016 
 
 
 
Figure 2: Number of people with HIV/Prevalence (A) and HIV/AIDS prevalence rate (B) 
by sex between 1990 and 2016 
 
 
 
 
   
Figure 3:   Number of HIV/AIDS deaths (A) and HIV/AIDS mortality rate (B) by 
age and sex in Ethiopia in 2016 
 
 
 
 
 
 Table 1: Number of deaths and mortality rate of HIV/AIDS in Ethiopia, both sex between 
1990 and 2016 
 
Year #Deaths 95%UI Rate/100,000 95%UI 
1990 8010 4577 13757 22.6 12.7 39.3 
1995 33603 22959 47611 81.6 55.1 116.0 
2000 67311 49199 87753 145.8 106.4 188.1 
2005 78494 64146 93937 149.8 125.0 175.1 
2010 42288 36169 49483 64.3 54.5 75.6 
2015 21785 17628 26552 27.2 21.9 34.3 
2016 19999 16426 24412 24.2 19.8 29.8 
 
Table 2: Number of DALY and DALY rate of HIV/AIDS in Ethiopia, both sex between 
1990 and 2016 
 
 
Year #DALY 95% UI 
DALY 
Rate/100,000 95%UI 
1990 443468 271301 739129 1119.9 671.2 1889.4 
1995 1830619 1292847 2565490 3952.3 2729.0 5542.1 
2000 3621372 2708814 4697687 6958.2 5130.4 9007.0 
2005 4166924 3359603 5019628 7055.9 5726.2 8407.5 
2010 2367533 2015111 2807693 3235.4 2792.2 3730.8 
2015 1245178 1010487 1505040 1401.0 1147.7 1658.7 
2016 1145962 941150 1419792 1253.8 1041.5 1510.5 
 
 
